Winslow Evans & Crocker’s Amedisys AMED Stock Holding History

Winslow Evans & Crocker’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-12	Closed	-$2K	–	1142
2019 Q1	$2K	Buy	+12	New	+$1.51K	﹤0.01%	1088

Other funds holding AMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Winslow Evans & Crocker's AMED Position: Q2 2019 in Review

Winslow Evans & Crocker sold out of Amedisys (AMED) in Q2 2019, closing a stake of 12 shares — an estimated $2K sold.

Winslow Evans & Crocker first reported a position in AMED in Q1 2019 and held it in 1 quarter. The position peaked at $2K in Q1 2019. 285 funds tracked by Wall St. Rank hold AMED as of Q2 2019.

Winslow Evans & Crocker reported no remaining Amedisys position as of Q2 2019 after selling out during the quarter.
Winslow Evans & Crocker sold 12 Amedisys shares in Q2 2019, an estimated $2K.
Winslow Evans & Crocker first reported a position in Amedisys in Q1 2019 and held it in 1 quarter.
Winslow Evans & Crocker's Amedisys position peaked at $2K in Q1 2019.
285 funds tracked by Wall St. Rank held Amedisys as of Q2 2019.

Based on Winslow Evans & Crocker's 13F filing for Q2 2019, filed 19 Jul 2019.